Health & Biotech
Health & Biotech
ASX Health Stocks: Neuren’s Q1 DAYBUE sales disappoint; 4DX gets another Medicare reimbursement in US
Health & Biotech
Weed Week: It’s showtime! Cannabis could come back from the dead as US makes biggest move in 50 years
Health & Biotech
ASX Quarterly Health Wrap: Which companies are making progress in clinical trials?
Health & Biotech
Melodiol delivers strong revenues in Q1 as US moves to reclassify cannabis
News
ASX Small Caps Lunch Wrap: Who found out there really are monsters in the walls this week?
News
Market Highlights: Wall Street in a sea of red, and cannabis stocks in focus after US report
Health & Biotech
ASX Quarterly Health Wrap: LTR Pharma firms up trial recruitment as Dimerix achieves key milestone
News
Things you may not know about Made in Australia, and ASX stocks that manufacture right here
News
Closing Bell: ASX up as unemployment rate ticks higher; BHP, Nimy Resources gain
Health & Biotech
Weed Week: A VAST majority of Americans now want marijuana to be legal
Health & Biotech
Neurotech’s Phase 2/3 autism trial meets primary endpoint
Health & Biotech
Melodiol unaudited revenue up 79% in Q1 FY24
News
Closing Bell: ASX crushed with all 11 sectors deep in the red, but there’s some good news from China
Health & Biotech
Bioxyne subsidiary granted upgraded wholesale licence for MDMA and psilocybin finished products
Health & Biotech
Neurotech hits new milestone in Phase II/III autism trial after treating last patient
Health & Biotech
Melodiol welcomes Chuck’s petition to pass US SAFER Banking Act
Health & Biotech